Cargando…
Recombinant human erythropoietin ameliorates cognitive dysfunction of APP/PS1 mice by attenuating neuron apoptosis via HSP90β
Autores principales: | Wan, Hua-Li, Zhang, Bing-Ge, Chen, Chongyang, Liu, Qian, Li, Ting, He, Ye, Xie, Yongmei, Yang, Xifei, Wang, Jian-Zhi, Liu, Gong-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076625/ https://www.ncbi.nlm.nih.gov/pubmed/35523771 http://dx.doi.org/10.1038/s41392-022-00998-w |
Ejemplares similares
-
Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole
por: Liu, Zhelong, et al.
Publicado: (2021) -
17-DMAG, an HSP90 Inhibitor, Ameliorates Multiple Organ Dysfunction Syndrome via Induction of HSP70 in Endotoxemic Rats
por: Wang, Yi-Li, et al.
Publicado: (2016) -
Erythropoietin ameliorates diabetes-associated cognitive dysfunction in vitro and in vivo
por: Wang, Meng, et al.
Publicado: (2017) -
The Therapeutic Roles of Recombinant Hsp90α on Cornea Epithelial Injury
por: Wang, Mingli, et al.
Publicado: (2022) -
Hematologic safety of chronic brain-penetrating erythropoietin dosing in APP/PS1 mice
por: Sun, Jiahong, et al.
Publicado: (2019)